The potential of tracer kinetic studies in drug development programs: A new investigational area for cancer research

Drug Information Journal

Volumn 31, Issue 3, 1997, Pages 1045-1049

  Price, P ^a   Harte, R ^a   Wells, P ^a   Brock, C ^a   Matthews, J ^a   Meikle, S ^a   Steel, C ^a   Luthra, J ^a   Osaman, S ^a   Brown, G ^a   Brady, F ^a   Prenant, C ^a   Jones, T ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

Cancer research; Drug development; Positron emission tomography; United Kingdom

Indexed keywords

ACRIDINE; AMIDE; CARBON 11; FLUORINE; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; GLUCOSE; NOLATREXED; RADIOISOTOPE; TEMOZOLOMIDE; THYMIDINE; THYMIDYLATE SYNTHASE INHIBITOR; TRACER;

ARTICLE; CANCER RESEARCH; CLINICAL TRIAL; CYCLOTRON; DRUG DEVELOPMENT; DRUG MECHANISM; GLUCOSE METABOLISM; HUMAN; MEAN RESIDENCE TIME; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHARMACOKINETICS; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; POSITRON; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TUMOR BLOOD FLOW;

EID: 0030751597     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286159703100349     Document Type: Article

References (6)

1. Strauss L. Kinetics and applications of F-18-fluorouracil in colorectal tumours. In: PET for drug development and evaluation. Comar D, Ed. Dordrecht, Boston, London: Kluwer Academic Publishers; 1995: 327-340.
2. Harte RJA, Matthews JC, Flavin A, Brock CS, Osman S, Luthra SK, Brown G, Brady F, Jones T, Bleehan N, Price P. Pre-phase I tracer kinetic studies in humans can contribute to new drug evaluation. 9th NCIEORTC Symposium on new drugs in cancer therapy. 1996:167;50.
3. Brock CS, Matthews JC, Brown G, Newlands ES, Price P. Demonstration and qualification of temozolomide uptake in vivo in human brain tumours. 9th NCI-EORTC Symposium on new drugs in cancer therapy. 1996:488;137.
4. Price P, Jones T. Can positron emission tomography (PET) be used to detect subclinical response to cancer therapy? Ear J Cancer. 1995;31A(12):1924-1927.
5. 11C]thymidine tracer kinetic studies in the assessment of anti-cancer therapy. Br J Cancer. 1996;April Supplement.
6. Cunningham VJ, Jones T. Spectral analysis of dynamic PET studies. J Cereb Blood Flow Metab. 1993; 13:15-23.